EDN ligands were upregulated in human [34, 54] and animal models [3, 5, 25, 40] of glaucoma, and intravitreal injection of EDN ligand was sufficient to drive caspase 3 activation in RGCs, which corresponded with later RGC death [44]. This evidence concerns the gene CASP3 and glaucoma.